Whitebox Advisors’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.66K Hold
174,000
﹤0.01% 631
2026
Q1
$11.6K Hold
174,000
﹤0.01% 529
2025
Q4
$6.77K Hold
174,000
﹤0.01% 470
2025
Q3
$6.54K Hold
174,000
﹤0.01% 403
2025
Q2
$6.14K Hold
174,000
﹤0.01% 353
2025
Q1
$5.74K Hold
174,000
﹤0.01% 278
2024
Q4
$8.13K Sell
174,000
-10,000
-5% -$618 ﹤0.01% 227
2024
Q3
$14.7K Hold
184,000
﹤0.01% 202
2024
Q2
$9.2K Hold
184,000
﹤0.01% 227
2024
Q1
$19.6K Hold
184,000
﹤0.01% 195
2023
Q4
$3.68K Hold
184,000
﹤0.01% 229
2023
Q3
$16.4K Hold
184,000
﹤0.01% 177
2023
Q2
$9.18K Hold
184,000
﹤0.01% 244
2023
Q1
$6.92K Hold
184,000
﹤0.01% 381
2022
Q4
$6.99K Hold
184,000
﹤0.01% 531
2022
Q3
$12K Hold
184,000
﹤0.01% 619
2022
Q2
$23K Hold
184,000
﹤0.01% 569
2022
Q1
$46K Sell
184,000
-16,000
-8% -$6.89K ﹤0.01% 608
2021
Q4
$158K Buy
+200,000
New +$147K ﹤0.01% 555

Other funds holding COCHW

Whitebox Advisors's COCHW Position: Q2 2026 in Review

Whitebox Advisors held its Envoy Medical Warrant (COCHW) position steady in Q2 2026 at 174,000 shares worth $8.66K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

Whitebox Advisors first reported a position in COCHW in Q4 2021 and has held it in 19 quarters since. The position peaked at $158K in Q4 2021. 32 funds tracked by Wall St. Rank hold COCHW as of Q2 2026.

  • Whitebox Advisors held 174,000 shares of Envoy Medical Warrant worth $8.66K as of Q2 2026.
  • Whitebox Advisors left its Envoy Medical Warrant share count unchanged in Q2 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Whitebox Advisors's portfolio in Q2 2026, its #631 holding.
  • Whitebox Advisors first reported a position in Envoy Medical Warrant in Q4 2021 and has held it in 19 quarters since.
  • Whitebox Advisors's Envoy Medical Warrant position peaked at $158K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.